High dose recombinant tumour necrosis factor (rTNF alpha) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancer.

Suppr

超能文献

作者信息

Lejeune F J

机构信息

Fondation du Centre Pluridisciplinaire d'Oncologie, CHUV, Lausanne, Switzerland.

出版信息

Eur J Cancer. 1995 Jun;31A(6):1009-16. doi: 10.1016/0959-8049(94)00512-5.

DOI:10.1016/0959-8049(94)00512-5

PMID:7646901

Abstract

摘要

相似文献

High dose recombinant tumour necrosis factor (rTNF alpha) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancer.

Eur J Cancer. 1995 Jun;31A(6):1009-16. doi: 10.1016/0959-8049(94)00512-5.

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.高剂量重组肿瘤坏死因子α联合干扰素γ和美法仑用于肢体隔离灌注治疗黑色素瘤和肉瘤

J Clin Oncol. 1992 Jan;10(1):52-60. doi: 10.1200/JCO.1992.10.1.52.

In transit metastases of malignant melanoma treated by high dose rTNF alpha in combination with interferon-gamma and melphalan in isolation perfusion.

World J Surg. 1992 Mar-Apr;16(2):234-40. doi: 10.1007/BF02071526.

Systemic and hemodynamic effects of recombinant tumor necrosis factor alpha in isolation perfusion of the limbs.重组肿瘤坏死因子α在肢体隔离灌注中的全身及血流动力学效应

Chest. 1995 Apr;107(4):1074-82. doi: 10.1378/chest.107.4.1074.

Administration of high-dose tumor necrosis factor alpha by isolation perfusion of the limbs. Rationale and results.通过肢体隔离灌注给予高剂量肿瘤坏死因子α。原理与结果。

J Infus Chemother. 1995 Spring;5(2):73-81.

[Value of isolation-perfusion of the limbs in melanomas and sarcomas].[肢体隔离灌注在黑色素瘤和肉瘤中的价值]

Ann Chir. 1995;49(1):9-12.

Isolation limb perfusion with tumor necrosis factor alpha and chemotherapy for advanced extremity soft tissue sarcomas.使用肿瘤坏死因子α和化疗进行隔离肢体灌注治疗晚期肢体软组织肉瘤。

Semin Oncol. 1997 Oct;24(5):547-55.

Regional therapy of melanoma.黑色素瘤的区域治疗

Eur J Cancer. 1993;29A(4):606-12. doi: 10.1016/s0959-8049(05)80163-7.

Rationale for using TNF alpha and chemotherapy in regional therapy of melanoma.在黑色素瘤区域治疗中使用肿瘤坏死因子α和化疗的理论依据。

J Cell Biochem. 1994 Sep;56(1):52-61. doi: 10.1002/jcb.240560110.

Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study.使用美法仑、肿瘤坏死因子和干扰素γ进行热灌注隔离肢体治疗肢体黑色素瘤患者：肿瘤坏死因子剂量递增研究结果

J Clin Oncol. 1996 Feb;14(2):479-89. doi: 10.1200/JCO.1996.14.2.479.

引用本文的文献

Targeting the Blood-Brain Tumor Barrier with Tumor Necrosis Factor-α.利用肿瘤坏死因子-α靶向血脑肿瘤屏障

Pharmaceutics. 2022 Jul 6;14(7):1414. doi: 10.3390/pharmaceutics14071414.

Synthesis and Evaluation of Paclitaxel-Loaded Gold Nanoparticles for Tumor-Targeted Drug Delivery.用于肿瘤靶向给药的紫杉醇负载金纳米颗粒的合成与评价

Bioconjug Chem. 2016 Nov 16;27(11):2646-2657. doi: 10.1021/acs.bioconjchem.6b00405. Epub 2016 Oct 18.

Remote spatiotemporally controlled and biologically selective permeabilization of blood-brain barrier.血脑屏障的远程时空控制及生物选择性通透

J Control Release. 2015 Nov 10;217:113-20. doi: 10.1016/j.jconrel.2015.08.044. Epub 2015 Aug 31.

Peptide-mediated targeting of cytokines to tumor vasculature: the NGR-hTNF example.多肽介导的细胞因子靶向肿瘤血管：NGR-hTNF 为例。

BioDrugs. 2013 Dec;27(6):591-603. doi: 10.1007/s40259-013-0048-z.

Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine.新型聚乙二醇化胶体金-rhTNF 纳米药物 CYT-6091 的 I 期和药代动力学研究。

Clin Cancer Res. 2010 Dec 15;16(24):6139-49. doi: 10.1158/1078-0432.CCR-10-0978. Epub 2010 Sep 27.

Tumor necrosis factor-alpha damages tumor blood vessel integrity by targeting VE-cadherin.肿瘤坏死因子-α 通过靶向血管内皮钙黏蛋白破坏肿瘤血管完整性。

Ann Surg. 2006 Nov;244(5):781-91. doi: 10.1097/01.sla.0000231723.81218.72.

Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas.肿瘤血管靶向剂NGR-TNF对小鼠淋巴瘤肿瘤微环境的影响。

Invest New Drugs. 2006 Jan;24(1):27-36. doi: 10.1007/s10637-005-4540-2.

Management of in-transit melanoma of the extremity with isolated limb perfusion.

Curr Treat Options Oncol. 2004 Jun;5(3):173-84. doi: 10.1007/s11864-004-0009-3.

Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration.通过血管靶向和屏障改变提高化疗药物在肿瘤中的渗透。

J Clin Invest. 2002 Aug;110(4):475-82. doi: 10.1172/JCI15223.

[The demonstration of the radiation-induced production of tumor necrosis factor-alpha in Ewing's sarcoma RM 82 in vitro and in vivo].

Strahlenther Onkol. 1997 Aug;173(8):407-14. doi: 10.1007/BF03038316.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验